Abstract
Platelet-activating factor (PAF) is a naturally occurring phospholipid that acts as a pleiotropic mediator and mediates cell-cell reactions under physiological and pathological conditions. Recently, it has been shown that PAF is a strong secretagogue of mucous glycoprotein in the airways, suggesting its role in mucous glycoprotein secretion and the pathogenesis of otitis media with effusion. In the current study, we examined the effect of PAF on mucous glycoprotein secretion in cultured chinchilla middle ear epithelial cells. PAF at 1 μM significantly stimulated mucous glycoprotein secretion from cultured chinchilla middle ear epithelial cells. This action was concentration-dependent, with secretions reaching near maximum when the cells were incubated with PAF at 100 μM. In a time-dependent study, PAF demonstrated an initial rapid stimulation of mucous glycoprotein secretion, followed by a gradual increase thereafter. A six-fold increase was seen in the first 2 h compared with controls. Cycloheximide, a protein synthesis inhibitor, demonstrated an inhibitory effect on PAF-stimulated mucous glycoprotein secretion in this study. These findings suggest that PAF plays an important role in the pathogenesis of otitis media with effusion by stimulating mucous glycoprotein secretion in vitro.
Similar content being viewed by others
References
Adler KB, Schwarz JE, Anderson WH, Welton AF (1987) Platelet activating factor stimulates secretion of mucin by explants of rodent airways in organ culture. Exp Lung Res 13: 25–43
Albert DH, Snyder F (1983) Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) from 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by rat alveolar macrophages. J Biol Chem 258:97–102
Amesara R, Kim Y, Sano S, Harada T, Juhn SK (1992) Primary cultures of middle ear epithelial cells from chinchillas. Eur Arch Otorhinolaryngol 249:164–167
Benveniste J (1974) Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils. Nature 249:581–582
Benveniste J (1979) Release of platelet activating factor by peritoneal and alveolar macrophages. Monogr Allergy 14: 138–141
Billah MM, Eckel S, Myers RF, Siegel MI (1986) Metabolism of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human promyelocytic leukemia L60 cells. Stimulated expression of phospholipase AZ and acetyltransferase requires differentiation. J Biol Chem 261:5824–5831
Camussi G, Aglietta M, Malavasi F, Tetta C, Piacibello W, Sanavio F, Bussolino F (1983) The release of platelet-activating factor from human endothelial cells in culture. J Immunol 131:2397–2403
Cauwenberge P van, Bernstein J (1987) Inflammatory mediators in middle ear diseaseT. In: Bernstein J, Ogra P (eds) Immunology of the ear. Raven Press, New York, p 338
Chilton FH, O'Flaherty JT, Walsh CE, et al (1982) Platelet-activaling factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. J Biol Chem 257:5402–5407
Chung KF, Aizawa H, Leikauf GD, Ueki IF, Evans TW, Hirose T, Nadel JA (1985) Airway hyperresponsiveness induced by PAF and suppression by thromboxane synthetase inhibitor. Am Rev Respir Dis 131: A279
Ganbo T, Hisamatsu K (1990) Mucosal dysfunction and damage induced by platelet activating factor (PAF). Acta Otolaryngol(Stockh) 110:427–436
Ganbo T, Hisamatsu K, Nakazawa T, Kamijo A, Murakami] Y (1991) Platelet activating factor (PAF) effects on ciliary activity of human paranasal sinus mucosa in vitro. Rhinology 29:231–237
Hamasaki Y, Mojarad M, Sagat T, Tai H, Said SI (1984) Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution. Am Rev Respir Dis 129: 742–746
Harada T, Kim Y, Juhn SK, Sakakura Y (1993) Biochemical characterization of mucous glycoproteins secreted by in vitro chinchilla middle ear epithelial cells. Eur Arch Otorhinolaryngol 250: 182–185
Harada T, Kim Y, Juhn SK, Sakakura Y (1993) Arachidonic acid metabolism by isolated and cultured middle ear epithelial cells from the chinchilla. Eur Arch Otorhinolaryngol 250: 220–223
Hwang S-B (1988) Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J Biol Chem 263:3225–3233
Koltai M, Hosford D, Guinot P, Esanu A, Braquet P (1991) Platelet-activating factor (PAF). A review of its effects, antagonists, and possible future clinical implications (parts I and II). Drugs 42:9–29, 174–204
Kramer RM, Patton GM, Prizker CR, Deykin D (1984) Metabolism of platelet-activating factor in human platelets. J Biol Chem 259:13316–13320
Lin AH, Morton DR, Gorman RR (1982) Acetyl glyceryl ether phosphocholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes. J Clin Invest 70:1058–1065
Lotner GZ, Lynch JM, Betz SJ, Henson PM (1980) Human neutrophil-derived platelet activating factor. J Immunol 124: 676–684
Lynch JM, Lotner GZ, Betz SJ, Henson PM (1979) The release of a platelet-activating factor by stimulated rabbit neutrophils. J Immunol 123:1219–1226
Mueller HW, O'Flaherty JT, Wykler RL (1983) Biosynthesis of platelet activating factor in rabbit polymorphonuclear neutrophils. J Biol Chem 258:6213–6218
Nakashima S, Suganuma A, Sato M, Tohmatsu T, Nozawa Y (1989) Mechanism of arachidonic acid libration in platelet-activating factor-stimulated human polymorphonuclear neutrophils. J Immunol 143:1295–1302
O'Flaherty JT, Jacobson DP, Redman JF (1989) Bidirectional effects of protein kinase C activators. Studies with human neutrophils and platelet-activating factor. J Biol Chem 264:6836–6843
Prescott SM, Zimmerman GA, McIntyre TM (1990) Plateletactivating factor (miniview). Biol Chem 265:17381–17384
Rhee CK, Jung TTK, Weeks D (1993) Experimental otitis media with effusion induced by platelet activating factor. Ann Otol Rhinol Laryngol 102:600–605
Saito H, Hirai A, Tamura Y, Yoshida S (1985) The 5-lipoxygenase products can modulate the synthesis of platelet activating factor (alkyl-acetyl GPC) in Ca-ionophore A23187-stimulated rat peritoneal macrophages. Prostaglandins Leukot Med 18:271–286
Sawyer DB, Anderson OS (1989) Platelet-activating factor is a general membrane perturbant. Biophys Acta 987:129–132
Shaw JO, Printz MP, Hirabayashi K, Henson PM (1978) Role of prostaglandin synthesis in rabbit platelet activation induced by basophil-derived platelet-activating factor. J Immunol 121: 1939–1945
Valone FH (1988) Identification of platelet-activating factor receptore in P388D1 murine macrophages. Immunology 140: 2389–2394
Valone FH, Goetzl EJ (1983) Specific binding by human polymorphonuclear leukocytes of the immunological mediator, 1O-hexadecyl/octadecyl-2-sn-glycero-3-phosphorylcholine. Immunology 48:141–149
Vargaftig BB, Chignard M, Benveniste J, Wal F (1981) Background and present status of research on platelet-activating factor (PAF-acether). Ann NY Acad Sci 370:119–137
Voelkel NF, Worthen S, Reeves JT, Henson PM, Murphy RC (1982) Nonimmunological production of leukotrienes induced by platelet activating factor. Science 218:286–288
Author information
Authors and Affiliations
Additional information
Supported by NIH grant P0I-D000133 from the National Institute on Deafness and Other Communication Disorders.
Rights and permissions
About this article
Cite this article
Lin, J., Kim, Y., Lees, C. et al. Effect of platelet-activating factor on secretion of mucous glycoprotein from chinchilla middle ear epithelial cells in vitro. Eur Arch Otorhinolaryngol 252, 92–96 (1995). https://doi.org/10.1007/BF00168027
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168027